Selected research
Market Structure
Global AI Pathology Analysis System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Pathology Analysis System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Pathology Analysis System include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte and Qritive, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Pathology Analysis System market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Pathology Analysis System and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Pathology Analysis System revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Pathology Analysis System market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Pathology Analysis System Segment by Company
Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics
AI Pathology Analysis System Segment by Type
On-premises
Cloud-based
AI Pathology Analysis System Segment by Application
Hospital
Clinic
Others
AI Pathology Analysis System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Analysis System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Pathology Analysis System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Pathology Analysis System industry.
Chapter 3: Detailed analysis of AI Pathology Analysis System companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Pathology Analysis Systemrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-premises
- Cloud-based
Applications
- Hospital
- Clinic
- Others
Companies covered
- Visiopharm
- PathAI
- Aiforia
- Indica Labs
- aetherAI
- Proscia
- Mindpeak
- Techcyte
- Qritive
- Deepathology
- Franklin.ai
- Roche Diagnostics
- Flagship
- Dedalus Group
- Ibex Medical Analytics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Pathology Analysis System Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 On-premises
- 1.2.3 Cloud-based
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Pathology Analysis System Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Pathology Analysis System Growth Trends by Region
- 1.5.1 Global AI Pathology Analysis System Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Pathology Analysis System Market Size by Region (2021-2026)
- 1.5.3 AI Pathology Analysis System Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Pathology Analysis System Market Dynamics
- 2.1 AI Pathology Analysis System Industry Trends
- 2.2 AI Pathology Analysis System Industry Drivers
- 2.3 AI Pathology Analysis System Industry Opportunities and Challenges
- 2.4 AI Pathology Analysis System Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Pathology Analysis System Revenue by Company (2021-2026)
- 3.2 Global AI Pathology Analysis System Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Pathology Analysis System Key Company Head office and Area Served
- 3.4 Global AI Pathology Analysis System Company, Product Type & Application
- 3.5 Global AI Pathology Analysis System Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Pathology Analysis System Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Pathology Analysis System Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Pathology Analysis System Tier 1, Tier 2, and Tier 3
4 AI Pathology Analysis System Market by Type
- 4.1 Global AI Pathology Analysis System Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Pathology Analysis System Market Size by Type (2021-2032)
- 4.3 Global AI Pathology Analysis System Market Size Share by Type (2021-2032)
5 AI Pathology Analysis System Market by Application
- 5.1 Global AI Pathology Analysis System Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Pathology Analysis System Market Size by Application (2021-2032)
- 5.3 Global AI Pathology Analysis System Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Visiopharm
- 6.1.1 Visiopharm Company Information
- 6.1.2 Visiopharm Business Overview
- 6.1.3 Visiopharm AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Visiopharm AI Pathology Analysis System Product Portfolio
- 6.1.5 Visiopharm Recent Developments
- 6.2 PathAI
- 6.2.1 PathAI Company Information
- 6.2.2 PathAI Business Overview
- 6.2.3 PathAI AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 PathAI AI Pathology Analysis System Product Portfolio
- 6.2.5 PathAI Recent Developments
- 6.3 Aiforia
- 6.3.1 Aiforia Company Information
- 6.3.2 Aiforia Business Overview
- 6.3.3 Aiforia AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Aiforia AI Pathology Analysis System Product Portfolio
- 6.3.5 Aiforia Recent Developments
- 6.4 Indica Labs
- 6.4.1 Indica Labs Company Information
- 6.4.2 Indica Labs Business Overview
- 6.4.3 Indica Labs AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Indica Labs AI Pathology Analysis System Product Portfolio
- 6.4.5 Indica Labs Recent Developments
- 6.5 aetherAI
- 6.5.1 aetherAI Company Information
- 6.5.2 aetherAI Business Overview
- 6.5.3 aetherAI AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 aetherAI AI Pathology Analysis System Product Portfolio
- 6.5.5 aetherAI Recent Developments
- 6.6 Proscia
- 6.6.1 Proscia Company Information
- 6.6.2 Proscia Business Overview
- 6.6.3 Proscia AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Proscia AI Pathology Analysis System Product Portfolio
- 6.6.5 Proscia Recent Developments
- 6.7 Mindpeak
- 6.7.1 Mindpeak Company Information
- 6.7.2 Mindpeak Business Overview
- 6.7.3 Mindpeak AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Mindpeak AI Pathology Analysis System Product Portfolio
- 6.7.5 Mindpeak Recent Developments
- 6.8 Techcyte
- 6.8.1 Techcyte Company Information
- 6.8.2 Techcyte Business Overview
- 6.8.3 Techcyte AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Techcyte AI Pathology Analysis System Product Portfolio
- 6.8.5 Techcyte Recent Developments
- 6.9 Qritive
- 6.9.1 Qritive Company Information
- 6.9.2 Qritive Business Overview
- 6.9.3 Qritive AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Qritive AI Pathology Analysis System Product Portfolio
- 6.9.5 Qritive Recent Developments
- 6.10 Deepathology
- 6.10.1 Deepathology Company Information
- 6.10.2 Deepathology Business Overview
- 6.10.3 Deepathology AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Deepathology AI Pathology Analysis System Product Portfolio
- 6.10.5 Deepathology Recent Developments
- 6.11 Franklin.ai
- 6.11.1 Franklin.ai Company Information
- 6.11.2 Franklin.ai Business Overview
- 6.11.3 Franklin.ai AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Franklin.ai AI Pathology Analysis System Product Portfolio
- 6.11.5 Franklin.ai Recent Developments
- 6.12 Roche Diagnostics
- 6.12.1 Roche Diagnostics Company Information
- 6.12.2 Roche Diagnostics Business Overview
- 6.12.3 Roche Diagnostics AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Roche Diagnostics AI Pathology Analysis System Product Portfolio
- 6.12.5 Roche Diagnostics Recent Developments
- 6.13 Flagship
- 6.13.1 Flagship Company Information
- 6.13.2 Flagship Business Overview
- 6.13.3 Flagship AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Flagship AI Pathology Analysis System Product Portfolio
- 6.13.5 Flagship Recent Developments
- 6.14 Dedalus Group
- 6.14.1 Dedalus Group Company Information
- 6.14.2 Dedalus Group Business Overview
- 6.14.3 Dedalus Group AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Dedalus Group AI Pathology Analysis System Product Portfolio
- 6.14.5 Dedalus Group Recent Developments
- 6.15 Ibex Medical Analytics
- 6.15.1 Ibex Medical Analytics Company Information
- 6.15.2 Ibex Medical Analytics Business Overview
- 6.15.3 Ibex Medical Analytics AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Ibex Medical Analytics AI Pathology Analysis System Product Portfolio
- 6.15.5 Ibex Medical Analytics Recent Developments
7 North America
- 7.1 North America AI Pathology Analysis System Market Size (2021-2032)
- 7.2 North America AI Pathology Analysis System Market Size by Type
- 7.2.1 North America AI Pathology Analysis System Market Size by Type (2021-2026)
- 7.2.2 North America AI Pathology Analysis System Market Size by Type (2027-2032)
- 7.2.3 North America AI Pathology Analysis System Market Share by Type (2021-2032)
- 7.3 North America AI Pathology Analysis System Market Size by Application
- 7.3.1 North America AI Pathology Analysis System Market Size by Application (2021-2026)
- 7.3.2 North America AI Pathology Analysis System Market Size by Application (2027-2032)
- 7.3.3 North America AI Pathology Analysis System Market Share by Application (2021-2032)
- 7.4 North America AI Pathology Analysis System Market Size by Country
- 7.4.1 North America AI Pathology Analysis System Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Pathology Analysis System Market Size by Country (2021-2026)
- 7.4.3 North America AI Pathology Analysis System Market Size by Country (2027-2032)
- 7.4.4 North America AI Pathology Analysis System Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Pathology Analysis System Market Size (2021-2032)
- 8.2 Europe AI Pathology Analysis System Market Size by Type
- 8.2.1 Europe AI Pathology Analysis System Market Size by Type (2021-2026)
- 8.2.2 Europe AI Pathology Analysis System Market Size by Type (2027-2032)
- 8.2.3 Europe AI Pathology Analysis System Market Share by Type (2021-2032)
- 8.3 Europe AI Pathology Analysis System Market Size by Application
- 8.3.1 Europe AI Pathology Analysis System Market Size by Application (2021-2026)
- 8.3.2 Europe AI Pathology Analysis System Market Size by Application (2027-2032)
- 8.3.3 Europe AI Pathology Analysis System Market Share by Application (2021-2032)
- 8.4 Europe AI Pathology Analysis System Market Size by Country
- 8.4.1 Europe AI Pathology Analysis System Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Pathology Analysis System Market Size by Country (2021-2026)
- 8.4.3 Europe AI Pathology Analysis System Market Size by Country (2027-2032)
- 8.4.4 Europe AI Pathology Analysis System Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Pathology Analysis System Market Size (2021-2032)
- 9.2 China AI Pathology Analysis System Market Size by Type
- 9.2.1 China AI Pathology Analysis System Market Size by Type (2021-2026)
- 9.2.2 China AI Pathology Analysis System Market Size by Type (2027-2032)
- 9.2.3 China AI Pathology Analysis System Market Share by Type (2021-2032)
- 9.3 China AI Pathology Analysis System Market Size by Application
- 9.3.1 China AI Pathology Analysis System Market Size by Application (2021-2026)
- 9.3.2 China AI Pathology Analysis System Market Size by Application (2027-2032)
- 9.3.3 China AI Pathology Analysis System Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Pathology Analysis System Market Size (2021-2032)
- 10.2 Asia AI Pathology Analysis System Market Size by Type
- 10.2.1 Asia AI Pathology Analysis System Market Size by Type (2021-2026)
- 10.2.2 Asia AI Pathology Analysis System Market Size by Type (2027-2032)
- 10.2.3 Asia AI Pathology Analysis System Market Share by Type (2021-2032)
- 10.3 Asia AI Pathology Analysis System Market Size by Application
- 10.3.1 Asia AI Pathology Analysis System Market Size by Application (2021-2026)
- 10.3.2 Asia AI Pathology Analysis System Market Size by Application (2027-2032)
- 10.3.3 Asia AI Pathology Analysis System Market Share by Application (2021-2032)
- 10.4 Asia AI Pathology Analysis System Market Size by Country
- 10.4.1 Asia AI Pathology Analysis System Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Pathology Analysis System Market Size by Country (2021-2026)
- 10.4.3 Asia AI Pathology Analysis System Market Size by Country (2027-2032)
- 10.4.4 Asia AI Pathology Analysis System Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Pathology Analysis System Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Pathology Analysis System Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Pathology Analysis System Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Pathology Analysis System Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Pathology Analysis System Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Pathology Analysis System Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Pathology Analysis System Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Pathology Analysis System Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Pathology Analysis System Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Pathology Analysis System Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Pathology Analysis System Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Pathology Analysis System Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Pathology Analysis System Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Pathology Analysis System Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst